We want to remind the research community about relevant NIH inclusion policies and resources, as well as where inclusion data can be found. Appropriate inclusion of research participants ensures that NIH supports science that will inform clinical practice to benefit all who are affected by the disease or condition under study.
We are committed to ensuring accountability and transparency of NIH research spending. To this end, we are sharing how we review and adapt our methodologies to provide accurate reports of NIH expenditures for NIH Research, Condition, and Disease Categorization (RCDC) categories.
To avoid the pitfalls that inconsistent use of terms can lead to, NIH and FDA developed a glossary of terms related to clinical research that could be used to assist the research community in effectively communicating about clinical trials. NIH and FDA are most interested in hearing community feedback on the utility of the glossary in its goal of promoting effective communications. Comments will be accepted until June 24, 2024.
Wondering about the implications for your application preparation? Consider participating in this live, virtual event on June 5, 2024 where NIH experts will provide insights
0 Comments